Listed

MiniMed Group, Inc.

MMEDNasdaqCIK 2062583HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$843.0m, Q1 FY2027
Operating income$5.0m, Q1 FY2027
Net income$0, Q1 FY2027
MiniMed Group, Inc., income statement, quarterly
Line itemUnitperiod not labelled2024-07-26period not labelled2024-10-25period not labelled2025-01-24period not labelled2025-04-25period not labelled2025-07-25period not labelled2025-10-24Q3 FY20262026-01-23Q4 FY20262026-04-24Q1 FY20272026-07-31
Revenue$mnot reportednot reported687Revenue, period not labelled, three months to 2025-01-24$687.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure724Revenue, period not labelled, three months to 2025-04-25$724.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure723Revenue, period not labelled, three months to 2025-07-25$723.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported790Revenue, Q3 FY2026, three months to 2026-01-23$790.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure837Revenue, Q4 FY2026, three months to 2026-04-24$837.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure843Revenue, Q1 FY2027, three months to 2026-07-31$843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Cost of revenue$mnot reportednot reported292Cost of revenue, period not labelled, three months to 2025-01-24$292.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure318Cost of revenue, period not labelled, three months to 2025-04-25$318.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure314Cost of revenue, period not labelled, three months to 2025-07-25$314.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported428Cost of revenue, Q3 FY2026, three months to 2026-01-23$428.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure357Cost of revenue, Q4 FY2026, three months to 2026-04-24$357.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure378Cost of revenue, Q1 FY2027, three months to 2026-07-31$378.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Gross profit$mnot reportednot reported395Gross profit, period not labelled, three months to 2025-01-24$395.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure405Gross profit, period not labelled, three months to 2025-04-25$405.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure409Gross profit, period not labelled, three months to 2025-07-25$409.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported362Gross profit, Q3 FY2026, three months to 2026-01-23$362.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure480Gross profit, Q4 FY2026, three months to 2026-04-24$480.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure465Gross profit, Q1 FY2027, three months to 2026-07-31$465.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Selling, general and administrative$mnot reportednot reported268Selling, general and administrative, period not labelled, three months to 2025-01-24$268.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure276Selling, general and administrative, period not labelled, three months to 2025-04-25$276.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure283Selling, general and administrative, period not labelled, three months to 2025-07-25$283.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported309Selling, general and administrative, Q3 FY2026, three months to 2026-01-23$309.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure299Selling, general and administrative, Q4 FY2026, three months to 2026-04-24$299.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure312Selling, general and administrative, Q1 FY2027, three months to 2026-07-31$312.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Operating income$mnot reportednot reported21.0Operating income, period not labelled, three months to 2025-01-24$21.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(148)Operating income, period not labelled, three months to 2025-04-25−$148.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(13.0)Operating income, period not labelled, three months to 2025-07-25−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported(100)Operating income, Q3 FY2026, three months to 2026-01-23−$100.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(93.0)Operating income, Q4 FY2026, three months to 2026-04-24−$93.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure5.0Operating income, Q1 FY2027, three months to 2026-07-31$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Income tax$mnot reportednot reported28.0Income tax, period not labelled, three months to 2025-01-24$28.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure21.0Income tax, period not labelled, three months to 2025-04-25$21.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure3.0Income tax, period not labelled, three months to 2025-07-25$3.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported12.0Income tax, Q3 FY2026, three months to 2026-01-23$12.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure93.0Income tax, Q4 FY2026, three months to 2026-04-24$93.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure4.0Income tax, Q1 FY2027, three months to 2026-07-31$4.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Net income$m(19.0)Net income, period not labelled, three months to 2024-07-26−$19.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(5.0)Net income, period not labelled, three months to 2024-10-25−$5.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(10.0)Net income, period not labelled, three months to 2025-01-24−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(172)Net income, period not labelled, three months to 2025-04-25−$172.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(19.0)Net income, period not labelled, three months to 2025-07-25−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure(5.0)Net income, period not labelled, three months to 2025-10-24−$5.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(119)Net income, Q3 FY2026, three months to 2026-01-23−$119.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(185)Net income, Q4 FY2026, three months to 2026-04-24−$185.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure0.0Net income, Q1 FY2027, three months to 2026-07-31$0. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Diluted EPS$ per sharenot reportednot reported(0.04)Diluted EPS, period not labelled, three months to 2025-01-24−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figurenot reported(0.08)Diluted EPS, period not labelled, three months to 2025-07-25−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported(0.47)Diluted EPS, Q3 FY2026, three months to 2026-01-23−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figurenot reported0.00Diluted EPS, Q1 FY2027, three months to 2026-07-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Basic EPS$ per sharenot reportednot reported(0.04)Basic EPS, period not labelled, three months to 2025-01-24−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figurenot reported(0.08)Basic EPS, period not labelled, three months to 2025-07-25−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported(0.47)Basic EPS, Q3 FY2026, three months to 2026-01-23−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figurenot reported0.00Basic EPS, Q1 FY2027, three months to 2026-07-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure

Balance sheet

Cash and equivalents$207.0m, Q1 FY2027
Shareholders' equity$3.62bn, Q1 FY2027
MiniMed Group, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-04-28period not labelled2024-04-26period not labelled2024-07-26period not labelled2024-10-25period not labelled2025-01-24period not labelled2025-04-25period not labelled2025-07-25period not labelled2025-10-24Q3 FY20262026-01-23FY20262026-04-24Q1 FY20272026-07-31
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reported11.0Cash and equivalents, period not labelled, at 2025-04-25$11.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figurenot reportednot reported10.0Cash and equivalents, Q3 FY2026, at 2026-01-23$10.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure298Cash and equivalents, FY2026, at 2026-04-24$298.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure207Cash and equivalents, Q1 FY2027, at 2026-07-31$207.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Current assets$mnot reportednot reportednot reportednot reportednot reported939Current assets, period not labelled, at 2025-04-25$939.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figurenot reportednot reported1,108Current assets, Q3 FY2026, at 2026-01-23$1.11bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure1,348Current assets, FY2026, at 2026-04-24$1.35bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure1,417Current assets, Q1 FY2027, at 2026-07-31$1.42bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Total assets$mnot reportednot reportednot reportednot reportednot reported4,201Total assets, period not labelled, at 2025-04-25$4.20bn. XBRL concept us-gaap:Assets. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figurenot reportednot reported4,343Total assets, Q3 FY2026, at 2026-01-23$4.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure4,630Total assets, FY2026, at 2026-04-24$4.63bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure4,718Total assets, Q1 FY2027, at 2026-07-31$4.72bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Current liabilities$mnot reportednot reportednot reportednot reportednot reported710Current liabilities, period not labelled, at 2025-04-25$710.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figurenot reportednot reported696Current liabilities, Q3 FY2026, at 2026-01-23$696.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure702Current liabilities, FY2026, at 2026-04-24$702.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure782Current liabilities, Q1 FY2027, at 2026-07-31$782.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Total liabilities$mnot reportednot reportednot reportednot reportednot reported871Total liabilities, period not labelled, at 2025-04-25$871.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figurenot reportednot reported881Total liabilities, Q3 FY2026, at 2026-01-23$881.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure1,019Total liabilities, FY2026, at 2026-04-24$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure1,098Total liabilities, Q1 FY2027, at 2026-07-31$1.10bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Shareholders' equity$m3,402Shareholders' equity, period not labelled, at 2023-04-28$3.40bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure3,448Shareholders' equity, period not labelled, at 2024-04-26$3.45bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure3,482Shareholders' equity, period not labelled, at 2024-07-26$3.48bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure3,462Shareholders' equity, period not labelled, at 2024-10-25$3.46bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure3,485Shareholders' equity, period not labelled, at 2025-01-24$3.48bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure3,330Shareholders' equity, period not labelled, at 2025-04-25$3.33bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure3,537Shareholders' equity, period not labelled, at 2025-07-25$3.54bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure3,560Shareholders' equity, period not labelled, at 2025-10-24$3.56bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure3,462Shareholders' equity, Q3 FY2026, at 2026-01-23$3.46bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure3,611Shareholders' equity, FY2026, at 2026-04-24$3.61bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure3,620Shareholders' equity, Q1 FY2027, at 2026-07-31$3.62bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure

Cash flow

Operating cash flow−$49.0m, Q1 FY2027
Capital expenditure$41.0m, Q1 FY2027
MiniMed Group, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2025-04-25period not labelled2025-07-25Q4 FY20262026-04-24Q1 FY20272026-07-31
Operating cash flow$m83.0Operating cash flow, period not labelled, three months to 2025-04-25$83.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(141)Operating cash flow, period not labelled, three months to 2025-07-25−$141.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure(170)Operating cash flow, Q4 FY2026, three months to 2026-04-24−$170.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(49.0)Operating cash flow, Q1 FY2027, three months to 2026-07-31−$49.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Capital expenditure$m57.0Capital expenditure, period not labelled, three months to 2025-04-25$57.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure53.0Capital expenditure, period not labelled, three months to 2025-07-25$53.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure56.0Capital expenditure, Q4 FY2026, three months to 2026-04-24$56.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure41.0Capital expenditure, Q1 FY2027, three months to 2026-07-31$41.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure

Shares

Diluted shares (weighted)281.00m, Q1 FY2027
MiniMed Group, Inc., shares, quarterly
Line itemUnitperiod not labelled2025-01-24period not labelled2025-07-25Q3 FY20262026-01-23Q1 FY20272026-07-31
Diluted shares (weighted)m shares253Diluted shares (weighted), period not labelled, three months to 2025-01-24252,813,348 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure253Diluted shares (weighted), period not labelled, three months to 2025-07-25252,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure253Diluted shares (weighted), Q3 FY2026, three months to 2026-01-23252,813,348 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure281Diluted shares (weighted), Q1 FY2027, three months to 2026-07-31281,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure

Shares outstanding: 281.35mShares outstanding, period not labelled, at 2026-09-03281,349,931 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure at Sep 3, 2026, from the cover of the 10-Q filed Sep 8, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.